The current results revealed that C16 alone or in combination with Ang-1 reduced the proliferation of GFAP+ reactive astrocytes by improving the inflammatory microenvironment, thereby exerting a neuroprotective effect on PD animals. Here, GFAP is linked to Parkinson disease.